In connection with the Board Meeting intimation dated October 17, 2024, Zenotech Laboratories has informed that the meeting of the Board of Directors of the Company was held today October 23, 2024 which commenced at 11:30 am and ended at 2:45 pm IST. The Board of Directors of the Company has: 1) Approval of unaudited standalone financial results for the quarter and half year ended September 30, 2024: Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the unaudited standalone financial results of the Company for the quarter and half year ended September 30, 2024, along with Limited Review Report issued by the Statutory Auditors of the Company, are enclosed as Annexure A. 2) Appointment of Chief Executive Officer (Key Managerial Personnel) of the Company: Based on the recommendation of Nomination and Remuneration Committee, the Board had appointed Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Company with immediate effect. Brief details about Sachin Laxmanappa Gavandare as required in compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, pertaining to his appointment are disclosed hereunder as Annexure B.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |